UNITED ~~STATESSECURITIES~~STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

~~Form~~FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934

For the month of February 2019

Commission File Number: 333-219066

Clementia Pharmaceuticals Inc.
(Translation of registrant's name into English)

1000 de la Gauchetiere Street West, Suite ~~1200Montreal~~1200 Montreal, Quebec, CANADA , H3B 4W5 (Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ X ] Form 40-F [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

The information contained in this Report (including the exhibits hereto) is hereby incorporated by reference into Clementia Pharmaceuticals Inc.’s Registration Statement on Form F-3 (File No. 333-227726).

On February 2628, 2019, the Registrant ~~issued~~provided a ~~press~~Notice ~~release,~~of aits ~~copy~~Annual ofGeneral Meeting which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. ~~(c) Exhibit 99.1. Press release dated February 26, 2019~~

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Clementia Pharmaceuticals Inc.	~~Clementia Pharmaceuticals Inc.~~
	(Registrant)	~~(Registrant)~~
Date: February 26, 2019		/s/ Steve Forte
Date: February 28, 2019
		Steve Forte
	/s/ Steve Forte
		Chief Financial Officer
	Steve Forte
	Chief Financial Officer

Filing Compare · Clementia Pharmaceuticals Inc.